Hikma, Teva, Sandoz Report Short Supply of Amoxicillin in US (1)

Three of the top four makers of the antibiotic amoxicillin, commonly used to treat bacterial infections in children, are reporting supply constraints in the US.

Hikma Pharmaceuticals Plc and Teva Pharmaceutical Industries Ltd. reported limited supply of several dosages of the drug to the University of Utah’s drug information service, which tracks medication shortages. Sandoz, a division of Novartis AG and one of the biggest generic drugmakers globally, is also facing supply constraints in the US as well as in other countries due to “significant” demand for the common antibiotic, a spokesperson said.

Amoxicillin can be prescribed for many ...